+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Enhanced mammary progesterone receptor-A isoform activity in the promotion of mammary tumor progression by dietary soy in rats

Enhanced mammary progesterone receptor-A isoform activity in the promotion of mammary tumor progression by dietary soy in rats

Nutrition and Cancer 62(6): 774-782

Dietary contribution to breast cancer risk, recurrence, and progression remains incompletely understood. Increased consumption of soy and soy isoflavones is associated with reduced mammary cancer susceptibility in women and in rodent models of carcinogenesis. In rats treated with N-methyl-N-nitrosourea, dietary intake of soy protein isolate (SPI) reduced mammary tumor occurrence but increased incidence of more invasive tumors in tumored rats, relative to the control diet casein. Here we evaluated whether mammary tumor progression in tumor-bearing rats lifetime exposed to SPI is associated with deregulated progesterone receptor (PR) isoform expression. In histologically normal mammary glands of rats with invasive ductal carcinoma lesions, PR-A protein levels were higher for SPI- than casein-fed rats, whereas PR-B was undetectable for both groups. Increased mammary PR-A expression was associated with higher transforming growth factor-beta1, stanniocalcin-1, and CD44 transcript levels; lower E-cadherin and estrogen receptor-alpha expression; and reduced apoptotic status in ductal epithelium. Serum progesterone (ng/ml) (CAS: 25.94 +/- 3.81; SPI: 13.19 +/- 2.32) and estradiol (pg/ml) (CAS: 27.9 +/- 4.49; SPI: 68.48 +/- 23.87) levels differed with diet. However, sera from rats of both diet groups displayed comparable mammosphere-forming efficiency in human MCF-7 cells. Thus, soy-rich diets may influence the development of more aggressive tumors by enhancing PR-A-dependent signaling in premalignant breast tissues.

(PDF emailed within 0-6 h: $19.90)

Accession: 052984990

Download citation: RISBibTeXText

PMID: 20661826

DOI: 10.1080/01635581.2010.494334

Related references

Chemoprevention by dietary dehydroepiandrosterone against promotion/progression phase of radiation-induced mammary tumorigenesis in rats. Journal Of Steroid Biochemistry & Molecular Biology. 54(1-2): 47-53, 1995

Effects of dietary polyamines on the promotion of mammary tumor in rats. Journal of Health Science 48(4): 376-380, August, 2002

Antitumor activity of the progesterone antagonists zk 98299 and ru 38486 in the hormone dependent mxt mammary tumor model of the mouse and the dmba and the mnu induced mammary tumor models of the rat. European Journal of Cancer & Clinical Oncology 25(4): 691-702, 1989

In vitro detection of immune responses to mammary tumor virus induced mammary tumors activity of spleen cell preparations from both mammary tumor virus free and mammary tumor virus infected mice. Journal Of Immunology: 693-705, 1974

Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Research 47(11): 2759-2762, 1987

Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. Journal of Nutrition 121(10): 1693-1698, 1991

Mammary tumor incidence, hormonal concentrations in serum, and receptor levels on the mammary gland in virgin and parous rats. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 268, 1994

Dietary protein enhanced mammary ornithine decarboxylase activity and tumorigenesis in rats. Journal of Nutrition 119(4): 547-552, 1989

Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. International Journal of Cancer 123(5): 1196-1204, 2008

Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. American Journal of Pathology 163(4): 1539-1549, 2003

Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proceedings of the National Academy of Sciences of the United States of America 100(17): 9744-9749, 2003

Nitric oxide-mediated promotion of murine mammary tumor progression Role in tumor cell migration. Proceedings of the American Association for Cancer Research Annual Meeting (41): 160, March, 2000

Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma. Bmc Veterinary Research 10(): 296-296, 2015

2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Research 61(20): 7449-7455, 2001

Oncogenes involved in progression in vitro of mammary tumor virus induced mammary tumor cells. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 530, 1986